Sanofi: Prostatic Hyperplasia trials
The registry lists 11 Prostatic Hyperplasia studies with Sanofi as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 6Phase 4 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Once Daily Given Alfuzosin in the Treatment of BPHCompletedNCT00637715Phase 4
- The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate ScoreCompletedNCT00540891Phase 3
- SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With AlfuzosinCompletedNCT00486785Phase 4
- ALF-STONE: Alfuzosin in Uretheric StonesTerminatedNCT00454402Phase 3
- Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic HyperplasiaCompletedNCT00409357Phase 2
- Sexuality And Management of Benign Prostatic Hyperplasia With AlfuzosinCompletedNCT00401661Phase 4
- Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic HyperplasiaCompletedNCT00399464Phase 3
- Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPHCompletedNCT00347061Phase 3
- ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPHCompletedNCT00290030Phase 3
- ALF-ONE : ALFuzosin ONcE DailyCompletedNCT00280605Phase 4
- Clinical Trial in Males With BPH (Enlarged Prostate)CompletedNCT00029822Phase 3